non hodgkin's lymphoma
Showing 1 - 25 of 29
Non Hodgkin's Lymphoma Trial in Beijing (TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T),
Not yet recruiting
- Non Hodgkin's Lymphoma
- TRAC and Power3 Genes Knock-out Allogeneic CD19-targeting CAR-T cell (ATHENA CAR-T)
- +2 more
-
Beijing, China
- +2 more
Aug 23, 2023
Non Hodgkin's Lymphoma Trial in Beijing (Allogenic CD19-CAR-?dT cell, Fludarabine, Cyclophosphamide)
Recruiting
- Non Hodgkin's Lymphoma
- Allogenic CD19-CAR-γδT cell
- +2 more
-
Beijing, Beijing, China
- +1 more
Jan 31, 2023
Non Hodgkin's Lymphoma Trial in Sacramento, Santa Rosa (Rituximab, Lenalidomide)
Active, not recruiting
- Non Hodgkin's Lymphoma
-
Sacramento, California
- +1 more
Nov 15, 2021
Non Hodgkin's Lymphoma, NHL, Aggressive NHL Trial in United States (Veltuzumab and 90Y-Epratuzumab Tetraxetan, 90Y-epratuzumab
Withdrawn
- Non Hodgkin's Lymphoma
- +3 more
- Veltuzumab and 90Y-Epratuzumab Tetraxetan
- +2 more
-
Newark, Delaware
- +6 more
Aug 12, 2021
Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Non Hodgkin's Lymphoma Trial in Wuhan (Fludarabine + Cyclophosphamide
Recruiting
- Acute Lymphocytic Leukemia
- +2 more
- Fludarabine + Cyclophosphamide + CAR-NK-CD19 Cells
-
Wuhan, Hubei, ChinaUnion Hospital, Huazhong University of Science and Technology
Apr 5, 2021
Non Hodgkin's Lymphoma Trial in Shijiazhuang (PEG-rhG-CSF)
Unknown status
- Non Hodgkin's Lymphoma
-
Shijiazhuang, Hebei, ChinaThe fourth hospital of Hebei Medical University
Aug 2, 2020
Hodgkin Lymphoma, Lymphocytic Leukemia, Mixed Cell Leukemia Trial run by the NCI (Stem cell transplantation)
Completed
- Hodgkin Lymphoma
- +8 more
- Stem cell transplantation
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 13, 2019
Leukemia, Non Hodgkin's Lymphoma, Aplastic Anemia Trial in Houston (Megadose T-cell Depleted HLA-nonidentical Blood Progenitor
Terminated
- Leukemia
- +2 more
- Megadose T-cell Depleted HLA-nonidentical Blood Progenitor Cell Transplantation
-
Houston, TexasMD Anderson Cancer Center
Oct 29, 2018
Hodgkin's Lymphoma, Leukemia, Myelodysplastic Syndrome(MDS) Trial in Baltimore (drug, radiation, biological)
Completed
- Hodgkin's Lymphoma
- +4 more
- Cyclophosphamide
- +7 more
-
Baltimore, MarylandSidney Kimmel Comprehensive Cancer Center
Oct 12, 2018
Chronic Lymphocytic Leukemia, GVHD, Hodgkin's Disease Trial run by the NCI (Th2 cells in allo HSCTT, Th2 Cells)
Completed
- Chronic Lymphocytic Leukemia
- +4 more
- Th2 cells in allo HSCTT
- Th2 Cells
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 3, 2018
Non Hodgkin's Lymphoma, Hodgkin Disease, Multiple Myeloma Trial in Boston (Fludarabine and total body irradiation, Total body
Terminated
- Non Hodgkin's Lymphoma
- +2 more
- Fludarabine and total body irradiation
- Total body irradiation
-
Boston, MassachusettsMassachusetts General Hospital
Mar 26, 2018
Multiple Myeloma, CLL / SLL, Non Hodgkin's Lymphoma Trial in Birmingham (drug, radiation, other)
Terminated
- Multiple Myeloma
- +4 more
- Fludarabine
- +2 more
-
Birmingham, AlabamaUniversity of Alabama in Birmingham BMT/CT Program Outpatient Cl
Jun 22, 2017
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia Trial in Singapore (infusion of allogeneic CIK
Completed
- Acute Myeloid Leukemia
- +6 more
- infusion of allogeneic CIK cells
-
Singapore, SingaporeSingapore General Hospital
Feb 9, 2017
Hodgkin's Disease, Non Hodgkin's Lymphoma, Myeloma Trial in Durham
Completed
- Hodgkin's Disease
- +4 more
-
Durham, North CarolinaDuke University Health System
May 3, 2016
Non Hodgkin's Lymphoma Trial in Indianapolis (clofarabine)
Completed
- Non Hodgkin's Lymphoma
-
Indianapolis, IndianaIndiana University Cancer Center
Sep 10, 2014
Hodgkin's Disease, Non Hodgkin's Lymphoma, Myeloma Trial in Durham (Non-myeloablative Stem Cell Transplantation)
Completed
- Hodgkin's Disease
- +4 more
- Non-myeloablative Stem Cell Transplantation
-
Durham, North CarolinaDuke University Health System
May 2, 2014
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia Trial in Erlangen (allogeneic donor derived
Unknown status
- Acute Myeloid Leukemia
- +7 more
- allogeneic donor derived B-lymphocytes
-
Erlangen, GermanyMedical Department 5, University Hospital Erlangen
Mar 24, 2014
Lymphoma, Non Hodgkin's Lymphoma, Hodgkin's Disease Trial in Germany (Plerixafor (AMD3100), Can be any registered nonpegylated
Completed
- Lymphoma
- +3 more
- Plerixafor (AMD3100)
- Can be any registered nonpegylated form of G-CSF
-
Berlin, Germany
- +4 more
Feb 10, 2014
Non Hodgkin's Lymphoma, Hepatitis B Trial in Taipei (Entecavir prophylaxis, Therapeutic entecavir)
Completed
- Non Hodgkin's Lymphoma
- Hepatitis B
- Entecavir prophylaxis
- Therapeutic entecavir
-
Taipei, TaiwanTaipei Veterans General Hospital-Division of Gastroenterology, D
May 27, 2013
Hodgkin's Lymphoma, Non Hodgkin's Lymphoma Trial in Toronto (PET Scan)
Completed
- Hodgkin's Lymphoma
- Non Hodgkin's Lymphoma
- PET Scan
-
Toronto, Ontario, CanadaUniversity Health Network, Princess Margaret Hospital
Dec 17, 2012
Chronic Myelogenous Leukemia, Multiple Myeloma, Non Hodgkin's Lymphoma Trial in Houston (CD8 Depleted Donor Lymphocyte)
Terminated
- Chronic Myelogenous Leukemia
- +4 more
- CD8 Depleted Donor Lymphocyte
-
Houston, TexasUT MD Anderson Cancer Center
Aug 22, 2012
Lymphoma, Non Hodgkin's Lymphoma Trial in San Juan (Cyclophosphamide, Doxorubicin, Vincristine and Prednisone)
Completed
- Lymphoma
- Non Hodgkin's Lymphoma
- Cyclophosphamide, Doxorubicin, Vincristine and Prednisone
-
San Juan, Puerto RicoHospital Auxilio Mutuo Cancer Center
Feb 3, 2012